Molecular features of primary mediastinal B-cell lymphoma:: involvement of p16INK4A, p53 and c-myc

被引:31
作者
Scarpa, A
Moore, PS
Rigaud, G
Inghirami, G
Montresor, M
Menegazzi, M
Todeschini, G
Menestrina, F
机构
[1] Univ Verona, Dipartimento Patol, Sez Anat Patol, I-37100 Verona, Italy
[2] Univ Verona, Dipartimento Sci Neurol & Vis, Sez Chim Biol, I-37100 Verona, Italy
[3] Univ Verona, Dipartimento Med Clin & Sperimentale, Sez Ematol, I-37100 Verona, Italy
[4] NYU, Med Ctr, Sch Med, Dept Pathol, New York, NY 10016 USA
[5] NYU, Med Ctr, Sch Med, Kaplan Comprehens Canc Ctr, New York, NY 10016 USA
关键词
mediastinal lymphoma; thymic lymphoma; p16(INK4A); p53; c-myc;
D O I
10.1046/j.1365-2141.1999.01678.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Primary mediastinal B-cell lymphoma (PMBL) shows chromosome 9p anomalies in 50% of cases. Based on reports that p16(INK4A) gene, located on this chromosomal arm, is frequently altered in aggressive lymphomas, we analysed for alterations of this gene in 27 cases of PMBL, which were part of a series of 32 PMBL cases that have been characterized for alterations in c-myc, p53, N-ras, bcl-1, bcl-2, bcl-6 and for Epstein-Barr virus (EBV) infection. Four cases showed p16(INK4A) gene anomalies, including three with promoter methylation and one homozygous deletion. Eight PMBLs showed c-myc rearrangements, Three additional cases showed sequence variations in the c-myc P2 promoter, two of which consisted of the same germline variation involving a novel polymorphic XhoI site. Pour tumours contained p53 gene mutations and three had clonal EBV infection. One case had a bcl-6 rearrangement. In conclusion, our study shows that p16(INK4), c-myc and p53 alterations occur in 15%, 25% and 13% of PMBLs, respectively. EBV monoclonality was found in 9% of cases, whereas no abnormality was detected in bcl-1, bcl-2 and N-ras. Thus, none of the common genetic aberrations seen in other types of non-Hodgkin's lymphomas appears to be stringently involved in the pathogenesis of this unique lymphoma type.
引用
收藏
页码:106 / 113
页数:8
相关论文
共 44 条
[1]  
Achille A, 1996, CANCER RES, V56, P3808
[2]   LARGE CELL LYMPHOMA OF THE MEDIASTINUM - A B-CELL TUMOR OF PROBABLE THYMIC ORIGIN [J].
ADDIS, BJ ;
ISAACSON, PG .
HISTOPATHOLOGY, 1986, 10 (04) :379-390
[3]   CDKN2A variants in a population-based sample of queensland families with melanoma [J].
Aitken, J ;
Welch, J ;
Duffy, D ;
Milligan, A ;
Green, A ;
Martin, N ;
Hayward, N .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (05) :446-452
[4]   THE HUMAN C-MYC-ONCOGENE - STRUCTURAL CONSEQUENCES OF TRANSLOCATION INTO THE IGH LOCUS IN BURKITT-LYMPHOMA [J].
BATTEY, J ;
MOULDING, C ;
TAUB, R ;
MURPHY, W ;
STEWART, T ;
POTTER, H ;
LENOIR, G ;
LEDER, P .
CELL, 1983, 34 (03) :779-787
[5]   Primary mediastinal large B-cell lymphoma - A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA (''Groupe d'Etude des Lymphomes de L'adulte'') study [J].
CazalsHatem, D ;
Lepage, E ;
Brice, P ;
Ferrant, A ;
dAgay, MF ;
Baumelou, E ;
Briere, J ;
Blanc, M ;
Gaulard, P ;
Biron, P ;
Schlaifer, D ;
Diebold, J ;
Audouin, J .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (07) :877-888
[6]   p21/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin's lymphomas: A potential marker of p53 tumor-suppressor gene function [J].
Chilosi, M ;
Doglioni, C ;
Magalini, A ;
Inghirami, G ;
Krampera, M ;
Nadali, G ;
Rahal, D ;
Pedron, S ;
Benedetti, A ;
Scardoni, M ;
Macri, E ;
Lestani, M ;
Menestrina, F ;
Pizzolo, G ;
Scarpa, A .
BLOOD, 1996, 88 (10) :4012-4020
[7]  
CORRADINI P, 1993, BLOOD, V81, P2708
[8]   EPSTEIN-BARR VIRUS (B95-8) DNA .7. MOLECULAR-CLONING AND DETAILED MAPPING [J].
DAMBAUGH, T ;
BEISEL, C ;
HUMMEL, M ;
KING, W ;
FENNEWALD, S ;
CHEUNG, A ;
HELLER, M ;
RAABTRAUB, N ;
KIEFF, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (05) :2999-3003
[9]   PRIMARY LARGE-CELL LYMPHOMA OF THE THYMUS - A DIFFUSE B-CELL NEOPLASM PRESENTING AS PRIMARY MEDIASTINAL LYMPHOMA [J].
DAVIS, RE ;
DORFMAN, RF ;
WARNKE, RA .
HUMAN PATHOLOGY, 1990, 21 (12) :1262-1268
[10]   The Myc negative autoregulation mechanism requires Myc-Max association and involves the c-myc P2 minimal promoter [J].
Facchini, LM ;
Chen, SJ ;
Marhin, WW ;
Lear, JN ;
Penn, LZ .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (01) :100-114